Poland· PL-100291193
Essentiale Max
A liver therapy product containing phospholipidum essentiale, registered in Poland by Opella Healthcare Poland Sp. z o.o.. The same ATC class is registered in 3 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Phospholipidum essentiale is registered in 3 of 19 countries.
Countries holding a registration under ATC A05BA (liver therapy), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 3 of them publish a price we can compare per daily dose
Phospholipidum essentiale · ATC A05BA
3 / 19 countries
- Belgiumprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Phospholipidum essentiale
- Manufacturer
- Opella Healthcare Poland Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- A05BA
- ATC class
- Liver therapy
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 3
- gtin05909991034474
- gtin05909991034481
- gtin05902502001040
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under A05BA
Liver therapy, as other registers publish it.
- PolandEsseliv forteAflofarm Farmacja Polska Sp. z o.o.
- PolandEsseliv MaxAflofarm Farmacja Polska Sp. z o.o.
- PolandEssentiale forteOpella Healthcare Poland Sp. z o.o.
- PolandHepa-MerzDelfarma Sp. z o.o.
- PolandHepa-MerzInPharm Sp. z o.o.
- PolandHepa-MerzDelfarma Sp. z o.o.
- PolandHepa-MerzAga Kommerz spol. s r.o.
- PolandHepa-Merz 3000Medezin Sp. z o.o.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/78a90b9b-c3f9-4b38-b41f-e2ad2a655e64 GET /v1/drugs/78a90b9b-c3f9-4b38-b41f-e2ad2a655e64?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Kapsułki twarde",
"source": "urpl",
"strength": "600 mg",
"packaging": "05909991034474 ¦ OTC ¦ 66770\n30 kaps.\n05909991034481 ¦ OTC ¦ 69830\n42 kaps.\n05902502001040 ¦ OTC ¦ 161889\n90 kaps.",
"substance": "Phospholipidum essentiale Mieszanina fosfolipidów zawierająca wolne od oleju wzbogacone fosfolipidy z nasion soi: 600 mg",
"common_name": "Phospholipidum essentiale",
"pl_product_id": "100291193",
"pozwolenie_nr": "20844",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about phospholipidum essentiale.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.